Bing Wu
Director/Miembro de la Junta en Beijing Shenogen Pharma Group Ltd. .
Cargos activos de Bing Wu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Director/Miembro de la Junta | 01/10/2019 | - |
Historial de carrera de Bing Wu
Formación de Bing Wu.
| Shanghai University of Finance & Economics | Graduate Degree |
Estadísticas
Internacional
| China | 3 |
Operativa
| Graduate Degree | 1 |
| Director/Board Member | 1 |
Sectorial
| Consumer Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Bolsa de valores
- Insiders
- Bing Wu
- Experiencia
